Solving the Fatty Liver Mistry: What’s in a Name? Understanding the Terminology Shift for Fatty Liver Disease Read more
Second Federal Trade Commission Report on Pharmacy Benefit Managers (PBM’s) Focuses on Specialty Generics Read more
John Marshall Unscripted Shaping the Future of Pancreatic Cancer: Insights from Julie Fleshman Read more
Health Advocacy Organizations and the Pharmaceutical Industry: An Analysis of Disclosure Practices or The Rothman’s Efforts to Undermine Public Health Read more
